article thumbnail

Mastering healthcare data governance with data lineage

IBM Business Partners

The healthcare industry faces arguably the highest stakes when it comes to data governance. The impact of healthcare data usage on people’s lives lies at the heart of why data governance in healthcare is so crucial.In healthcare, managing the accuracy, quality and integrity of data is the focus of data governance.

article thumbnail

Top 8 TMF Consulting Firms, Consultants, and Outsourcing Companies

Jake Jorgovan

eZen Inc eZen Inc drives innovation across healthcare providers, medical device manufacturers, and pharmaceutical and biotechnology industries with high-quality software, engineering, and talent solutions. Their services cater to the unique needs of pharmaceutical and biotechnology companies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top 10 Clinical Operations Consultants & Consulting Firms

Jake Jorgovan

SDS Clinical LLC: Provides comprehensive clinical trial consulting, excelling in governance, team management, and operational optimization, specifically tailored for navigating complexities in clinical program development in regulated environments.

article thumbnail

Avance Clinical Earns Frost & Sullivan’s 2023 Best Practices Customer Value Leadership Award for Delivering High-quality Clinical Trials Based on Globally Accepted Data

Frost & Sullivan

San Antonio, TX — 7 th Aug, 2023 — Frost & Sullivan recently researched the Asia-Pacific biotechnology contract research organization industry and, based on its findings, recognizes Avance Clinical with the 2023 Customer Value Leadership Award. and rapid start-up regulatory processes that are available in Australia.

article thumbnail

Frost & Sullivan Reveals How Virtual Care will Impact the Trillion-dollar Global Healthcare Market

Frost & Sullivan

Pharmaceuticals and biotechnology, IVD, advanced medical technologies, medical imaging and informatics, and digital health expected to hit over $2.6 trillion by 2025. Santa Clara, Calif. trillion by 2025, growing at a compound annual growth rate of 6.3%. About Frost & Sullivan.

article thumbnail

Pharma and Biotech to Highly Invest in RNA Therapeutics to Expedite Research & Development across the Globe

Frost & Sullivan

Additionally, the growth opportunities exposed by the initial commercialization of mRNA vaccines, antisense oligonucleotides (ASOs) and short interfering RNA (siRNA)-based therapeutics are further attracting pharmaceutical and biotechnology companies to invest in this space and expedite research and development (R&D).

Biotech 98
article thumbnail

The Outbreak of COVID-19 Unlocked the Demand for Antimicrobial Technologies

Frost & Sullivan

Further, the need for antimicrobial technology as a macro form of COVID-19 prevention and to reduce the risk of rapid spreading will raise the global government interest in antimicrobic surface, biofilm, and coating adoption in building, construction, and food packaging by 2025. For further information on this analysis, please click here.